Skip to main content
. 2026 Aug 27;14(9):741. doi: 10.3390/vaccines14090741
2vHPV Bivalent HPV vaccine
4vHPV Quadrivalent HPV vaccine
9vHPV Nonavalent HPV vaccine
APC At least partial coverage
CI Confidence interval
CU Completely unprotected
HIS Hospital Information System
HPV Human papillomavirus
HR-HPV High-risk human papillomavirus
IARC International Agency for Research on Cancer
IRB Institutional Review Board
LIS Laboratory Information System
O/E Observed/expected ratio
OPD Outpatient department
PCR Polymerase chain reaction
SD Standard deviation
STROBE Strengthening the Reporting of Observational Studies in Epidemiology
TCT Thinprep cytologic test
WHO World Health Organization